drugset / Trial / NCT04278651
Early Antenatal Support for Iron Deficiency Anemia
Phase 4
Recruiting
80 enrolled
Thomas Jefferson University
Auerbach Hematology and Oncology · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Timeline
- Start
- 2021-09-29
- Primary completion
- 2026-08-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | 325 mg | Oral |
| Subject | Ferumoxytol | Diagnostic / imaging agent | 510 mg | Intravenous |